CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Non Randomized Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02000375
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:25.200010+00:00
Published At: 2016-09-29T00:00:00+00:00
Record Updated At: 2016-09-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Metastatic Breastcancer", "Estrogen Receptor Positive Breast Cancer", "Estrogen Receptor Negative Neoplasm", "Progesterone Receptor Positive Tumor", "Progesterone Receptor Negative Neoplasm", "Androgen Receptor Gene Overexpression"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-09-29"
protocolSection.identificationModule.nctId: "NCT02000375"
protocolSection.identificationModule.officialTitle: "A Phase II Non Randomized Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.